Affluent Medical SA
EPA:AFME.PA
1.765 (EUR) • At close November 12, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 1.224 | 1.339 | 1.451 | 0.824 | 1.429 | 0.043 | 0.003 |
| Kosten van de omzet
| 2.424 | 2.443 | 2.518 | 3.108 | 2.26 | 5.996 | 3.798 |
| Brutowinst
| -1.2 | -1.104 | -1.067 | -2.284 | -0.831 | -5.953 | -3.795 |
| Brutowinstmarge
| -0.98 | -0.824 | -0.735 | -2.772 | -0.582 | -138.442 | -1,265 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0.052 | 0.023 | 0.009 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 11.787 | 5.162 | 5.189 | 3.332 | 12.952 | 2.429 | 1.787 |
| Verkoop- en marketingkosten
| 0.079 | 0.081 | 0.02 | 0.021 | 0.038 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 11.866 | 5.243 | 5.209 | 3.353 | 12.99 | 2.429 | 1.787 |
| Overige kosten
| -0.097 | 6.578 | 5.526 | 6.133 | -0.034 | 1.977 | 1.507 |
| Bedrijfskosten
| 11.866 | 11.821 | 10.735 | 9.486 | 13.024 | 4.406 | 3.294 |
| Bedrijfsresultaat
| -13.066 | -14.29 | -13.233 | -12.594 | -15.284 | -10.295 | -7.089 |
| Bedrijfsresultaat ratio
| -10.675 | -10.672 | -9.12 | -15.284 | -10.696 | -239.419 | -2,363 |
| Totaal overige inkomsten en kosten netto
| -2.737 | -3.517 | -2.01 | -1.536 | -1.412 | -0.126 | -0.133 |
| Inkomen voor belasting
| -15.803 | -15.4 | -15.257 | -14.528 | -16.696 | -10.421 | -7.222 |
| Inkomen voor belasting ratio
| -12.911 | -11.501 | -10.515 | -17.631 | -11.684 | -242.349 | -2,407.333 |
| Belastingkosten
| 0.15 | -0.173 | -0.437 | -0.209 | -1.297 | -1.669 | -1.386 |
| Nettowinst
| -15.653 | -15.227 | -14.82 | -14.319 | -16.589 | -8.752 | -5.837 |
| Nettowinstmarge
| -12.788 | -11.372 | -10.214 | -17.377 | -11.609 | -203.535 | -1,945.667 |
| WPA (Winst Per Aandeel)
| -0.54 | -0.81 | -0.8 | -0.77 | -0.89 | -0.74 | -0.48 |
| Verwaterde WPA
| -0.54 | -0.81 | -0.8 | -0.77 | -0.89 | -0.72 | -0.48 |
| EBITDA
| -13.343 | -13.214 | -10.888 | -10.474 | -12.552 | -9.967 | -6.937 |
| EBITDA ratio
| -10.901 | -8.81 | -7.473 | -12.737 | -9.114 | -232.372 | -2,281.667 |